Skip to main content
. 2020 Apr;9(2):709–721. doi: 10.21037/tau.2020.03.10

Table 2. Characteristics of intra-cavernous injection drugs in the diagnosis of vascular erectile dysfunction.

Drugs Pharmacological Mean dose Minimal dose Maximal dose Sensitivity Side effect rate Adverse effect
Papaverine opium alkaloid 17 mg 2 mg 90 mg 91% 13% Pain; anxiety; fibrosis; priapism; infections; ecchymosis; penile lump
Papaverine + Phentolamine α-adrenergic blocking agent 15 mg + 0.4 mg 10 mg + 0.25 mg 80 mg + 10 mg 93% 30%
Alprostadil α1-adrenergic blocking agent 12 µg 1 µg 40 µg 80% 13%